Home > Inhibitors & Agonists > Apoptosis > RIP kinase
Cat. No. Product name CAS No.
DC11620 RIPK2-IN-8

A potent, selective, orally available RIPK2 inhibitor with IC50 of 3 nM.

2141969-56-2
DC10787 GSK2982772 Featured

GSK2982772 is a potent and ATP competitive RIP1 inhibitor with an IC50 of 16 nM.

1622848-92-3
DC9721 GSK2983559 active metabolite Featured

GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.

1423186-80-4
DC9733 GSK583 Featured

GSK583 is a Highly Potent and Selective Inhibitor of RIP2 Kinase (RIP2K bing IC50=5 nM; rat in vivo PD IC50 = 50 nM).

1346547-00-9
DC10471 GSK-872 Featured

GSK-872 is a potent and selective RIPK3 (receptor-interacting protein kinase-3) inhibitor.

1346546-69-7
DC12045 HS-1371 Featured

HS-1371 is a novel kinase inhibitor of RIP3-mediated necroptosis.

2158197-70-5
DC10389 RIPA-56

RIPA-56 is a highly potent, selective, and metabolically stable inhibitor of receptor-interacting protein 1 (RIP1) with an IC50 of 13 nM.

1956370-21-0
DC10373 WEHI-345 Featured

WEHI-345 is a potent and selective inhibitor of RIPK2, with IC50 of 0.13 μM.

1354825-58-3
DC28704 RIP2 kinase inhibitor 1

RIP2 kinase inhibitor 1 (compound 11) is a potent and selective receptor interacting protein 2 (RIP2) kinase inhibitor with an IC50 of 0.03 μM for RIP2 FP. RIP2 kinase inhibitor 1 is used for autoinflammatory disorders.

2380028-10-2
Page 1 / Total 1 FirstPrevNextLastGoto